This thesis describes several clinical and molecular aspects of DCIS and provides potential progression markers that could contribute to the development of personalized treatment strategies in patients with DCIS

, , ,
F.J. van Kemenade (Folkert) , C.H.M. van Deurzen (Carolien)
Erasmus University Rotterdam
hdl.handle.net/1765/127411
Erasmus MC Cancer Institute

Doebar, S. C. (2020, May 20). Ductal carcinoma in situ: the journey to invasive breast cancer. Retrieved from http://hdl.handle.net/1765/127411